SCHEMBL6813952

SCHEMBL6813952

O=C(O)c1cc2cnc[nH]c-2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.42
IDO1 P14902 1/20 0.42
KMO O15229 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
TSHR P16473 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GABRA1 P14867 1/20 0.40
NFKB1 P19838 1/20 0.40
GABRR1 P24046 1/20 0.40
GABRR2 P28476 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
HPGDS O60760 1/20 0.40
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
PMP22 Q01453 1/20 0.39
CYP2E1 P05181 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6217754 0.79 TLK2 (0.39) CYP3A4IDO1TSHRALDH1A1GABRA1
SCHEMBL6638123 0.76 CYP3A4 (0.60) CYP3A4IDO1MKNK1MKNK2TSHR
SCHEMBL940610 0.75 IDO1 (0.59) CYP3A4IDO1KMOHPGDSCYP2E1
SCHEMBL3008680 0.74 RXRA (0.46) CYP3A4IDO1ALDH1A1HPGDSMAPT
SCHEMBL16517301 0.73 NOTUM (0.48) KMOMKNK1MKNK2ALDH1A1KDM4E
SCHEMBL2593988 0.72 IDO1 (0.42) CYP3A4IDO1MAPTCYP2E1CYP2D6
SCHEMBL3181717 0.70 MKNK1 (0.69) KMOMKNK1MKNK2ALDH1A1KDM4E
4-Imidazolecarboxylic Acid SCHEMBL317725 0.70
SCHEMBL28134052 0.69 MKNK1 (0.62) KMOMKNK1MKNK2TSHRALDH1A1
4-Imidazolecarboxylic Acid SCHEMBL28747764 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014916-A1 PYRIMIDINE FUSED BICYCLIC METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO claimed
WO-2004014916-A1 PYRIMIDINE FUSED BICYCLIC METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed